{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T07:18:00Z","timestamp":1773299880564,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2010,3,31]],"date-time":"2010-03-31T00:00:00Z","timestamp":1269993600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2011,6]]},"DOI":"10.1007\/s12032-010-9472-9","type":"journal-article","created":{"date-parts":[[2010,3,30]],"date-time":"2010-03-30T18:31:58Z","timestamp":1269973918000},"page":"528-531","source":"Crossref","is-referenced-by-count":5,"title":["Combination of simvastatin and imatinib sensitizes the CD34+ cells in K562 to cell death"],"prefix":"10.1007","volume":"28","author":[{"given":"Rui","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ding","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shijie","family":"Mu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,3,31]]},"reference":[{"key":"9472_CR1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","volume":"96","author":"MW Deininger","year":"2000","unstructured":"Deininger MW, Goldman JM, Melo JV. The molecular biology of chronic myeloid leukemia. Blood. 2000;96:3343\u201356.","journal-title":"Blood"},{"key":"9472_CR2","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1056\/NEJMoa062867","volume":"355","author":"BJ Druker","year":"2006","unstructured":"Druker BJ, Guilhot F, O\u2019Brien SG, Gathmann I, Kantarjian H, Gattermann N, et al. Five-year follow-up of patients receiving imatinib for chronic myeloid leukemia. N Engl J Med. 2006;355:2408\u201317.","journal-title":"N Engl J Med"},{"key":"9472_CR3","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1038\/sj.leu.2405086","volume":"22","author":"H Konig","year":"2008","unstructured":"Konig H, Holtz M, Modi H, Manley P, Holyoake TL, Forman SJ, et al. Enhanced BCR-ABL kinase inhibition does not result in increased inhibition of downstream signaling pathways or increased growth suppression in CML progenitors. Leukemia. 2008;22:748\u201355.","journal-title":"Leukemia"},{"key":"9472_CR4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cell.2007.01.003","volume":"128","author":"Z Tothova","year":"2007","unstructured":"Tothova Z, Kollipara R, Huntly BJ, Lee BH, Castrillon DH, Cullen DE, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell. 2007;128:325\u201339.","journal-title":"Cell"},{"key":"9472_CR5","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","volume":"463","author":"K Naka","year":"2010","unstructured":"Naka K, Hoshii T, Muraguchi T, Tadokoro Y, Ooshio T, Kondo Y, Nakao S, Motoyama N, Hirao A. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature. 2010;463:676\u201380.","journal-title":"Nature"},{"key":"9472_CR6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nature08040","volume":"459","author":"J Liu","year":"2009","unstructured":"Liu J, Cao L, Chen J, Song S, Lee IH, Quijano C, et al. Bmi1 regulates mitochondrial function and the DNA damage response pathway. Nature. 2009;459:387\u201392.","journal-title":"Nature"},{"key":"9472_CR7","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1182\/blood-2009-03-209734","volume":"114","author":"A Rizo","year":"2009","unstructured":"Rizo A, Olthof S, Han L, Vellenga E, de Haan G, Schuringa JJ. Repression of BMI1 in normal and leukemic human CD34(+) cells impairs self-renewal and induces apoptosis. Blood. 2009;114:1498\u2013505.","journal-title":"Blood"},{"key":"9472_CR8","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1172\/JCI1500","volume":"101","author":"O Hernandez-Perera","year":"1998","unstructured":"Hernandez-Perera O, Perez-Sala D, Navarro-Antolin J, Sanchez-Pascuala R, Hernandez G, Diaz C, et al. Effects of the 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors, atorvastatin and simvastatin, on the expression of endothelin-1 and endothelial nitric oxide synthase in vascular endothelial cells. J Clin Invest. 1998;101:2711\u20139.","journal-title":"J Clin Invest"},{"key":"9472_CR9","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1161\/01.CIR.99.2.216","volume":"99","author":"JF Plehn","year":"1999","unstructured":"Plehn JF, Davis BR, Sacks FM, Rouleau JL, Pfeffer MA, Bernstein V, et al. Reduction of stroke incidence after myocardial infarction with pravastatin: the cholesterol and recurrent events (CARE) study. The care investigators. Circulation. 1999;99:216\u201323.","journal-title":"Circulation"},{"key":"9472_CR10","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1161\/01.CIR.98.9.839","volume":"98","author":"PM Ridker","year":"1998","unstructured":"Ridker PM, Rifai N, Pfeffer MA, Sacks FM, Moye LA, Goldman S, et al. Inflammation, pravastatin, and the risk of coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events (CARE) investigators. Circulation. 1998;98:839\u201344.","journal-title":"Circulation"},{"key":"9472_CR11","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","volume":"335","author":"FM Sacks","year":"1996","unstructured":"Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and recurrent events trial investigators. N Engl J Med. 1996;335:1001\u20139.","journal-title":"N Engl J Med"},{"key":"9472_CR12","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","volume":"279","author":"JR Downs","year":"1998","unstructured":"Downs JR, Clearfield M, Weis S, Whitney E, Shapiro DR, Beere PA, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS. Air force\/texas coronary atherosclerosis prevention study. Jama. 1998;279:1615\u201322.","journal-title":"Jama"},{"key":"9472_CR13","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1002\/ijc.23593","volume":"123","author":"SJ Cho","year":"2008","unstructured":"Cho SJ, Kim JS, Kim JM, Lee JY, Jung HC, Song IS. Simvastatin induces apoptosis in human colon cancer cells and in tumor xenografts, and attenuates colitis-associated colon cancer in mice. Int J Cancer. 2008;123:951\u20137.","journal-title":"Int J Cancer"},{"issue":"5","key":"9472_CR14","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1016\/j.cellsig.2009.12.010","volume":"22","author":"N Ghosh-Choudhury","year":"2010","unstructured":"Ghosh-Choudhury N, Mandal CC, Ghosh-Choudhury N, Ghosh Choudhury G. Simvastatin induces derepression of PTEN expression via NFkappaB to inhibit breast cancer cell growth. Cell Signal. 2010;22(5):749\u201358.","journal-title":"Cell Signal"},{"issue":"1","key":"9472_CR15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10549-009-0507-x","volume":"119","author":"ER Garwood","year":"2010","unstructured":"Garwood ER, Kumar AS, Baehner FL, Moore DH, Au A, Hylton N, Flowers CI, Garber J, Lesnikoski BA, Hwang ES, Olopade O, Port ER, Campbell M, Esserman LJ. Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer. Breast Cancer Res Treat. 2010;119(1):137\u201344.","journal-title":"Breast Cancer Res Treat"},{"key":"9472_CR16","doi-asserted-by":"crossref","first-page":"8707","DOI":"10.1158\/0008-5472.CAN-05-4061","volume":"66","author":"MJ Campbell","year":"2006","unstructured":"Campbell MJ, Esserman LJ, Zhou Y, Shoemaker M, Lobo M, Borman E, et al. Breast cancer growth prevention by statins. Cancer Res. 2006;66:8707\u201314.","journal-title":"Cancer Res"},{"key":"9472_CR17","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1055\/s-2003-37501","volume":"111","author":"H Seeger","year":"2003","unstructured":"Seeger H, Wallwiener D, Mueck AO. Statins can inhibit proliferation of human breast cancer cells in vitro. Exp Clin Endocrinol Diabetes. 2003;111:47\u20138.","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"9472_CR18","doi-asserted-by":"crossref","first-page":"7386","DOI":"10.1158\/0008-5472.CAN-07-0993","volume":"67","author":"S Kotamraju","year":"2007","unstructured":"Kotamraju S, Williams CL, Kalyanaraman B. Statin-induced breast cancer cell death: role of inducible nitric oxide and arginase-dependent pathways. Cancer Res. 2007;67:7386\u201394.","journal-title":"Cancer Res"},{"key":"9472_CR19","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1159\/000235907","volume":"84","author":"YC Yang","year":"2009","unstructured":"Yang YC, Xiao DW, Liu H, Chuan LM, Zeng YL, Zhou DA, et al. Mechanism of simvastatin-induced K562 cell apoptosis. Pharmacology. 2009;84:191\u20135.","journal-title":"Pharmacology"},{"key":"9472_CR20","doi-asserted-by":"crossref","unstructured":"Marques DS, Sandrini JZ, Boyle RT, Marins LF, Trindade GS. Relationships between multidrug resistance (MDR) and stem cell markers in human chronic myeloid leukemia cell lines. Leuk Res. 2009.","DOI":"10.1016\/j.leukres.2009.11.004"},{"key":"9472_CR21","doi-asserted-by":"crossref","first-page":"8031","DOI":"10.1158\/0008-5472.CAN-08-1490","volume":"68","author":"ML Heaney","year":"2008","unstructured":"Heaney ML, Gardner JR, Karasavvas N, Golde DW, Scheinberg DA, Smith EA, et al. Vitamin C antagonizes the cytotoxic effects of antineoplastic drugs. Cancer Res. 2008;68:8031\u20138.","journal-title":"Cancer Res"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9472-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-010-9472-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-010-9472-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,3]],"date-time":"2020-06-03T11:26:25Z","timestamp":1591183585000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-010-9472-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,3,31]]},"references-count":21,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011,6]]}},"alternative-id":["9472"],"URL":"https:\/\/doi.org\/10.1007\/s12032-010-9472-9","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,3,31]]}}}